Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | APEX nuclease (multifunctional DNA repair enzyme) 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0192 | 0.1689 | 1 |
Toxoplasma gondii | SWIRM domain-containing protein | 0.008 | 0.0571 | 0.338 |
Schistosoma mansoni | SWI/SNF complex-related | 0.008 | 0.0571 | 0.062 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.0192 | 0.1689 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1024 | 1 | 1 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0192 | 0.1689 | 1 |
Echinococcus granulosus | SWI:SNF complex subunit SMARCC2 | 0.008 | 0.0571 | 0.062 |
Schistosoma mansoni | amine oxidase | 0.0192 | 0.1689 | 0.1836 |
Loa Loa (eye worm) | hypothetical protein | 0.0944 | 0.9202 | 0.9202 |
Loa Loa (eye worm) | hypothetical protein | 0.0192 | 0.1689 | 0.1689 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.0192 | 0.1689 | 1 |
Brugia malayi | SWIRM domain containing protein | 0.008 | 0.0571 | 0.0571 |
Onchocerca volvulus | 0.1024 | 1 | 0.5 | |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0192 | 0.1689 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.1213 | 0.1213 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.0571 | 0.0571 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0192 | 0.1689 | 1 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0272 | 0.2487 | 0.2487 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.0192 | 0.1689 | 1 |
Mycobacterium ulcerans | monoamine oxidase | 0.0192 | 0.1689 | 1 |
Brugia malayi | hypothetical protein | 0.0192 | 0.1689 | 0.1689 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.0192 | 0.1689 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.008 | 0.0571 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.1213 | 0.1213 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0944 | 0.9202 | 1 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.0192 | 0.1689 | 0.5 |
Giardia lamblia | hypothetical protein | 0.008 | 0.0571 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0192 | 0.1689 | 1 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0023 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0023 | 0 | 0.5 |
Entamoeba histolytica | SWIRM domain protein | 0.008 | 0.0571 | 1 |
Mycobacterium ulcerans | dehydrogenase | 0.0192 | 0.1689 | 1 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.0192 | 0.1689 | 0.5 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0192 | 0.1689 | 0.1836 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0023 | 0 | 0.5 |
Leishmania major | UDP-galactopyranose mutase | 0.0192 | 0.1689 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0192 | 0.1689 | 1 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0944 | 0.9202 | 1 |
Echinococcus multilocularis | protoporphyrinogen oxidase | 0.0192 | 0.1689 | 0.1836 |
Mycobacterium ulcerans | oxidoreductase | 0.0192 | 0.1689 | 1 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0192 | 0.1689 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0944 | 0.9202 | 0.9202 |
Entamoeba histolytica | hypothetical protein | 0.008 | 0.0571 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0192 | 0.1689 | 0.1689 |
Plasmodium vivax | hypothetical protein, conserved | 0.0192 | 0.1689 | 1 |
Mycobacterium ulcerans | protoporphyrinogen oxidase | 0.0192 | 0.1689 | 1 |
Echinococcus multilocularis | 0.0192 | 0.1689 | 0.1836 | |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0944 | 0.9202 | 1 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.0192 | 0.1689 | 1 |
Echinococcus multilocularis | SWI:SNF complex subunit SMARCC2 | 0.008 | 0.0571 | 0.062 |
Schistosoma mansoni | Protoporphyrinogen oxidase chloroplast/mitochondrial precursor | 0.0192 | 0.1689 | 0.1836 |
Entamoeba histolytica | SWIRM domain protein | 0.008 | 0.0571 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0272 | 0.2487 | 0.2487 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0192 | 0.1689 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.008 | 0.0571 | 1 |
Schistosoma mansoni | amine oxidase | 0.0192 | 0.1689 | 0.1836 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.1213 | 0.1213 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0192 | 0.1689 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.2239 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 8.4368 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.